Clinical and Laboratory Impact of Postpartum Enoxaparin Prophylaxis After Vaginal Delivery: A Retrospective Cohort Study

What is known on this subject?Venous thromboembolism is a leading cause of maternal morbidity and mortality postpartum.Low molecular weight heparin is recommended for prophylaxis in moderate-to high-risk women.Limited data exist on the effects of enoxaparin on wound healing and laboratory parameters. What this study adds?This study demonstrates that prophylactic enoxaparin after vaginal delivery is not associated with significant bleeding, wound complications, or changes in routine hematological parameters.Risk-based enoxaparin prophylaxis appears feasible and safe, but largescale prospective studies are needed to confirm these findings and determine the optimal dose and treatment duration.